Trial intelligence / Profile preview

Dexmedetomidine as an adjuvant to ropivacaine for pediatric ilioinguinal block

2013-000122-60Phase 4Active

Sponsor
Karolinska University Hospital
Start
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Karolinska University Hospital. Primary endpoints: Duration of ilioinguinal iliohypogastric nerve block and Need for postoperative pain therapy. Started Mar 2013; status: active.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2013-000122-60.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000122-60.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call